Diabetes mellitus and health-related quality of life in prostate cancer: 5-year results from the Prostate Cancer Outcomes Study

BJU International

Volumn 107, Issue 8, 2011, Pages 1223-1231

  Thong, Melissa S Y ^a   Van De Poll Franse, Lonneke ^a,b   Hoffman, Richard M ^c   Albertsen, Peter C ^d   Hamilton, Ann S ^e   Stanford, Janet L ^f   Penson, David F ^g  

^a TILBURG UNIVERSITY   (Netherlands)

^b The Netherlands   (Netherlands)

^c UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

^e UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^f USA   (United States)

^g VANDERBILT UNIVERSITY   (United States)

Author keywords

diabetes mellitus; health related quality of life; prostate cancer; symptoms

Indexed keywords

ADULT; AGED; ARTICLE; CANCER HORMONE THERAPY; CANCER INCIDENCE; CANCER RADIOTHERAPY; CANCER SURVIVAL; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE DURATION; FOLLOW UP; HEALTH STATUS; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; QUALITY ADJUSTED LIFE YEAR; SEXUAL FUNCTION; URINARY TRACT FUNCTION; WATCHFUL WAITING;

ADULT; AGED; COMORBIDITY; DIABETES MELLITUS; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PROGNOSIS; PROSTATIC NEOPLASMS; QUALITY OF LIFE; REPRODUCTION; RETROSPECTIVE STUDIES; SEER PROGRAM; SURVIVAL RATE; TIME FACTORS; UNITED STATES; URINATION;

EID: 79954555951     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2010.09861.x     Document Type: Article

References (29)

1. National Institute of Diabetes and Digestive and Kidney Diseases. National Diabetes Statistics, 2007 Fact Sheet. Bethesda, MD: U.S. Department of Health and Human Services, National Institutes of Health, 2008
2. Houterman S, Janssen-Heijnen ML, Hendrikx AJ, van den Berg HA, Coebergh JW,. Impact of comorbidity on treatment and prognosis of prostate cancer patients: a population-based study. Crit Rev Oncol Hematol 2006; 58: 60-7
3. van de Poll-Franse LV, Houterman S, Janssen-Heijnen MLG, Dercksen MW, Coebergh JWW, Haak HR,. Less aggressive treatment and worse overall survival in cancer patients with diabetes: a large population based analysis. Int J Cancer 2007; 120: 1986-92 (Pubitemid 46418378)
4. Hall HI, Satariano WA, Thompson T, Ragland KE, Van Den Eeden SK, Selvin S,. Initial treatment for prostate carcinoma in relation to comorbidity and symptoms. Cancer 2002; 95: 2308-15 (Pubitemid 35351136)
5. Pinkawa M, Gagel B, Piroth MD, et al,. Erectile dysfunction after external beam radiotherapy for prostate cancer. Eur Urol 2009; 55: 227-34
6. Karakiewicz PI, Bhojani N, Neugut A, et al,. The effect of comorbidity and socioeconomic status on sexual and urinary function and on general health-related quality of life in men treated with radical prostatectomy for localized prostate cancer. J Sex Med 2008; 5: 919-27 (Pubitemid 351472202)
7. Mols F, Aquarius AE, Essink-Bot ML, Aaronson NK, Kil PJ, van de Poll-Franse LV,. Does diabetes mellitus as a comorbid condition affect the health-related quality of life in prostate cancer survivors? Results of a population-based observational study. BJU Int 2008; 102: 1594-600
8. Keating NL, O'Malley AJ, Smith MR,. Diabetes and cardiovascular disease during androgen deprivation therapy for prostate cancer. J Clin Oncol 2006; 24: 4448-56 (Pubitemid 46630983)
9. van de Poll-Franse LV, Sadetsky N, Kwan L, Litwin MS,. Severity of cardiovascular disease and health-related quality of life in men with prostate cancer: a longitudinal analysis from CaPSURE. Qual Life Res 2008; 17: 845-55
10. van de Poll-Franse LV, Kwan L, Reiter RE, Lee SP, Litwin MS,. The influence of cardiovascular disease on health related quality of life in men with prostate cancer: a 4-year followup study. J Urol 2008; 179: 1362-7
11. Latini DM, Chan JM, Cowan JE, et al,. Health-related quality of life for men with prostate cancer and diabetes: a longitudinal analysis from CaPSURE. Urology 2006; 68: 1242-7 (Pubitemid 44895459)
12. Potosky AL, Davis WW, Hoffman RM, et al,. Five-year outcomes after prostatectomy or radiotherapy for prostate cancer: the prostate cancer outcomes study. J Natl Cancer Inst 2004; 96: 1358-67 (Pubitemid 39406169)
13. Potosky AL, Harlan LC, Stanford JL, et al,. Prostate cancer practice patterns and quality of life: the Prostate Cancer Outcomes Study. J Natl Cancer Inst 1999; 91: 1719-24 (Pubitemid 29518766)
14. Ware J Jr,. SF-36 Health Survey: Manual and Interpretation Guide. Boston, MA: The Health Institute, New England Medical Center, 1993
15. Norman GR, Sridhar FG, Guyatt GH, Walter SD,. Relation of distribution- and anchor-based approaches in interpretation of changes in health-related quality of life. Med Care 2001; 39: 1039-47 (Pubitemid 33691379)
16. Norman GR, Sloan JA, Wyrwich KW,. Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation. Med Care 2003; 41: 582-92
17. Fowler FJ Jr, Barry MJ, Lu-Yao G, Roman A, Wasson J, Wennberg JE,. Patient-reported complications and follow-up treatment after radical prostatectomy. The National Medicare Experience: 1988-1990 (updated June 1993). Urology 1993; 42: 622-9 (Pubitemid 24004781)
18. Litwin MS, Hays RD, Fink A, Ganz PA, Leake B, Brook RH,. The UCLA Prostate Cancer Index: development, reliability, and validity of a health-related quality of life measure. Med Care 1998; 36: 1002-12 (Pubitemid 128456439)
19. Talcott JA, Rieker P, Clark JA, et al,. Patient-reported symptoms after primary therapy for early prostate cancer: results of a prospective cohort study. J Clin Oncol 1998; 16: 275-83 (Pubitemid 28041609)
20. Stanford JL, Feng Z, Hamilton AS, et al,. Urinary and sexual function after radical prostatectomy for clinically localized prostate cancer: the Prostate Cancer Outcomes Study. JAMA 2000; 283: 354-60 (Pubitemid 30051753)
21. Talcott JA, Manola J, Clark JA, et al,. Time course and predictors of symptoms after primary prostate cancer therapy. J Clin Oncol 2003; 21: 3979-86 (Pubitemid 46606212)
22. Stava CJ, Beck ML, Feng L, Lopez A, Busaidy N, Vassilopoulou-Sellin R,. Diabetes mellitus among cancer survivors. J Cancer Surviv 2007; 1: 108-15
23. Skinner TC, Carey ME, Cradock S, et al,. Diabetes education and self-management for ongoing and newly diagnosed (DESMOND): process modelling of pilot study. Patient Educ Couns 2006; 64: 369-77 (Pubitemid 44772976)
24. Absetz P, Oldenburg B, Hankonen N, et al,. Type 2 diabetes prevention in the real world: three year results of the GOAL lifestyle implementation trial. Diabetes Care 2009; 32: 1418-20
25. Galvao DA, Spry N, Taaffe DR, et al,. A randomized controlled trial of an exercise intervention targeting cardiovascular and metabolic risk factors for prostate cancer patients from the RADAR trial. BMC Cancer 2009; 9: 419
26. Tuomilehto J, Lindstrom J, Eriksson JG, et al,. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001; 344: 1343-50 (Pubitemid 32378388)
27. Schwarz PEH, Li J, Lindstrom J, Tuomilehto J,. Tools for predicting the risk of type 2 diabetes in daily practice. Horm Metab Res 2009; 41: 86-97
28. Klabunde CN, Reeve BB, Harlan LC, Davis WW, Potosky AL,. Do patients consistently report comorbid conditions over time? results from the prostate cancer outcomes study. Med Care 2005; 43: 391-400 (Pubitemid 40515628)
29. Litwin MS, McGuigan KA,. Accuracy of recall in health-related quality-of-life assessment among men treated for prostate cancer. J Clin Oncol 1999; 17: 2882-8 (Pubitemid 29415248)